During the past decade, Renown Institute for Heart and Vascular Health conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Renown Institute for Heart and Vascular Health" #1 sponsor was "Abbott Medical Devices" with 1 trials, followed by "Amgen" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "ReCor Medical, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Renown Institute for Heart and Vascular Health" are "Atherosclerotic Cardiovascular Disease" (1 trials), "Atrial Fibrillation" (1 trials), "Bradycardia" (1 trials), "COVID-19 Pneumonia" (1 trials) and "Heart Disease" (1 trials). Many other conditions were trialed in "Renown Institute for Heart and Vascular Health" in a lesser frequency.

Most popular intervention types in "Renown Institute for Heart and Vascular Health" are "Device" (2 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cardiac Rhythm Management device" (1 trials), "Lp(a) Screening" (1 trials), "Sham Procedure" (1 trials), "The Paradise® Renal Denervation Ultrasound System" (1 trials) and "Tociliuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Renown Institute for Heart and Vascular Health" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Renown Institute for Heart and Vascular Health". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Renown Institute for Heart and Vascular Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Renown Institute for Heart and Vascular Health, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".